Sign in

Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer.

Ji LuKun ZhouXiaoxing YinHan XuBaojin Ma
Published in: Comput. Biol. Chem. (2019)
Keyphrases